Vanda

Aug 14, 2018

Vanda Wins Denial of Petition For Rehearing on Fanapt®

Jun 01, 2018

Vanda Pharmaceuticals Announces Participation at June 2018 Investor Conferences

May 07, 2018

Vanda Pharmaceuticals to Present at the Deutsche Bank 43rd Annual Health Care Conference

Apr 18, 2018

Vanda Pharmaceuticals to Announce First Quarter 2018 Financial Results on May 2, 2018

Mar 15, 2018

Vanda Pharmaceuticals Inc. Prices Public Offering of Common Stock

Mar 14, 2018

Vanda Pharmaceuticals Inc. Proposes Public Offering of Common Stock

Jan 30, 2018

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2017 Financial Results on February 14, 2018

Nov 13, 2017

Vanda Pharmaceuticals Announces Participation at November 2017 Investor Conferences

Nov 10, 2017

Vanda Receives Negative Opinion for Marketing Authorization from the European Medicines Agency on Fanaptum(TM) for the Treatment of Schizophrenia

Oct 10, 2017

Vanda Pharmaceuticals Announces Participation at the Oppenheimer Specialty Pharma Summit Conference

Sep 29, 2017

Vanda to Present Scientific Posters at World Sleep 2017

Sep 11, 2017

Vanda Pharmaceuticals Announces Participation at September 2017 Investor Conferences

Sep 06, 2017

Vanda Pharmaceuticals Announces Participation at the Citi 12th Annual Biotech Conference

Jun 05, 2017

Vanda Pharmaceuticals Announces Participation at June 2017 Investor Conferences